Midi Health Semaglutide Review 2026

Two things make Midi unusual in this market at once: it charges no membership fee, and it is genuinely in-network rather than merely willing to file paperwork for you.

There is no subscription to cancel. You pay per visit — covered where Midi is in-network with your plan, or $250 for a 30-minute first visit and $150 for 15-minute follow-ups self-pay. Medication is priced separately, with Midi's compounded GLP-1 starting at $164 per four-week supply including shipping and supplies, and brand-name prescriptions sent to a pharmacy of your choice.

Midi states it is in-network with most major insurance providers nationwide and available in all 50 states, while noting plainly that coverage depends on your plan and that deductibles, coinsurance and copays may still apply. It says it serves more than 450,000 women.

Why the clinical framing matters here

Midi's clinicians are trained specifically in women's health and weight management, covering hormone change, metabolism and lifestyle factors. The first visit reviews weight history, current medications, previous treatments and risk factors before anything is prescribed, and targeted labs such as blood sugar or cholesterol may be ordered to guide care.

That matters because rapid weight loss during the menopause transition is a different clinical problem. Oestrogen decline already accelerates loss of muscle and bone, and a GLP-1 that drives fast weight loss compounds it. A clinician who treats that as the starting point rather than a complication is worth more than a lower vial price.

The arithmetic to run before choosing

Pay-per-visit cuts both ways. If Midi is in-network for you, the visits are covered and you are paying $164 for medication — which would place it among the better-value options here. If it is not, a first quarter with two follow-ups is $550 in visits plus roughly $492 in medication.

One more caveat on the medication price: $164 is a floor, varying by medication, format and dose, with no published ceiling. Ask what it costs at the dose and format you would actually use.

What compounded semaglutide actually is

Semaglutide is the active ingredient in Ozempic and Wegovy, both FDA-approved products from Novo Nordisk. A compounded version is prepared by a pharmacy rather than manufactured by Novo Nordisk, and it is not an FDA-approved product. FDA has not evaluated it for safety, effectiveness or quality.

That distinction is the single most important thing to understand before buying. The efficacy data you have read about — the 15% average body-weight reduction, the cardiovascular outcomes — comes from trials of the branded product. Those results are routinely used to sell compounded versions that were never in the trials.

Dosing typically starts at 0.25 mg weekly and escalates over several months toward a maintenance dose, which is why dose-dependent pricing matters so much: a plan that looks cheap at the starting dose can cost several times more by the time you reach a therapeutic one.

The common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation — and are usually worst in the days after a dose increase. They are the main reason people stop. Slower titration and adequate fibre and fluid intake are the standard mitigations.

Before you buy from anyone

1. Get the total monthly cost in writing — medication plus any membership, not the headline figure.
2. Ask whether the price changes as your dose increases. This is where most of the money is lost.
3. Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
4. Confirm what happens if you stop after one month, and whether there is an auto-rebill.
5. Ask whether a refund is available if a provider declines to prescribe.
6. Tell the prescriber every medication and supplement you take, including anything bought online.